Company / Cash per Share
Avidity Biosciences, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.78
FY2025
5-year range
$1.97 / $7.74
FY2021-FY2025
Trend
+41.0%
vs FY2024
Sector context
#77 of 205
Health Care
What the data says
At $2.78, Avidity Biosciences, Inc.'s cash per share ranks #77 of 205 in the Health Care sector. Cash per Share returned to growth in FY2025 after 5 years of decline, reaching $2.78.
Based on SEC 10-K filings.
2.78 in FY2025 with a 5-year CAGR of -28.5%.
Improved from $2.53 to $2.78 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -24.8%
- 5-Year CAGR
- -28.5%
- 10-Year CAGR
- -
Sector benchmark
#77 of 205 in Health CareTop 38% of 205This company $2.78 Sector average $72.93
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 41.0% year-over-year.
- Ranks #77 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.78 | +41.0% |
| FY2024 | $1.97 | -22.3% |
| FY2023 | $2.53 | -61.2% |
| FY2022 | $6.53 | -15.6% |
| FY2021 | $7.74 | -47.9% |
| FY2020 | $14.84 | -57.4% |
| FY2019 | $34.86 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026